Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
8.80
-0.16 (-1.79%)
Mar 3, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Pharmaceuticals
144.93M33.22M34.51M28.27M32.10M
Pharmaceuticals Growth
336.33%-3.74%22.07%-11.94%47.48%
Total
144.93M33.22M34.51M28.27M32.10M
Total Growth
336.33%-3.74%22.07%-11.94%47.48%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
United States
144.93M33.22M34.51M28.27M32.10M
United States Growth
336.33%-3.74%22.07%-11.94%47.48%
Total
144.93M33.22M34.51M28.27M32.10M
Total Growth
336.33%-3.74%22.07%-11.94%47.48%
Source: S&P Global Market Intelligence.